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Identity 




2050 base-pairs DNA linear, starts at 30624573 and 
ends at 3064506 bp from pter with plus strand 
orientation. This gene contains 1 exon. 
Transcription 
The transcription produces 1 spliced mRNA variant 





The transcription of this gene gives 1 spliced mRNA 
that encodes 1 protein isoform with 217 aa and 22848 
Da of molecular weight. 
Expression 
Pituitary gland (71,08%), lung (14,44%), intestine 
(6,87%), eye (6,56%), and brain (1,05%). 
Localisation 
This is a multi-pass membrane protein localized in the 














Claudin-9 belongs to the claudin family. Claudins 
constitute integral membrane proteins responsible for 
solute and electrolyte permeability of the tight junction 
that serve as a physical barrier to prevent solutes and 
water from passing freely through the paracellular 
space between epithelial or endothelial cell sheets. 
Tight junctions also play a critical role in maintai ing 
cell polarity and signal transductions. Claudin-9 creates 
charge specific channels in the paracellular space, plays 
a major role in tight junction-specific obliteration f the 
intercellular space, through calcium-independent cell-
adhesion activity, is required to preserve sensory cells 
in the hearing organ because claudin-9-defective tight 
junctions fail to shield the basolateral side of hair cells 
from the K+-rich endolymph. Its ion barrier function is 
essential in the cochlea, but appears to be dispensable 
in other organs. Is one of the entry cofactors for 
hepatitis C virus; it enables HCV entry into target c lls 
just as efficiently as CLDN1. 
Homology 
The CLDN9 gene is conserved in chimpanzee, dog, 




Abnormal claudin expression has been documented in 
several malignancies. Strong claudin-9  
expression was associated with higher mortality rate 
(66%) in the diffuse- vs the intestinal-type (25%) 
gastric adenocarcinoma after a 2-year follow-up 
(Rendón-Huerta et al., 2010).  
Claudin-9 expression is closely related to gastric 
carcinogenesis, and their detection is a useful 
prognostic marker in gastric adenocarcinoma.  
Claudin-9 overexpression in AGS cells enhanced their 
invasive potential (1,6-fold), cell migration and 
proliferation rate (13,3%); it also increased claudin-1 
and zonula occludens-1 levels (Zavala et al., 2011).  
Increased expression of claudin-9 is sufficient to 
enhance tumorigenic properties of a gastric 
adenocarcinoma cell line. 
Hepatitis C virus infection 
Note 
Claudin-9 mediates the entry of HCV into target cells. 
CLDN9 is expressed in the liver, the primary site of 
HCV replication, and peripheral blood mononuclear 
cells, an additional site of HCV replication. Sequenc  
comparison and mutagenesis studies, showed that 
residues N38 and V45 in the first extracellular loop of 
CLDN9 are necessary for HCV entry (Zheng et al., 
2007). 
Claudin-9 expressed in CD81+ (tetraspanin) cells also 
enables the entry of HCV pseudoparticles. Claudin -1 
and -9 function equally well as entry cofactors in 
endothelial cells but claudin-1 is more efficient in
hepatoma cells (Meertens et al., 2008). This suggests 
that additional cellular factors modulate the ability of 
claudins to function as HCV entry cofactors. 
 











Claudin-9 is required for the preservation of sensory 
cells in the hearing organ because its absence in a 
specific subdomain underneath more apical tight-
junction strands formed by other claudins, fails to 
shield the basolateral side of hair cells from the K+-rich 
endolymph (Nakano et al., 2009). Claudin-9 mutant 
mice have shown that even the deeper (subapical) tight-




Epigenetic regulators such as TSA, 5-aza, and DMSO 
significantly enhance the expression of claudin-9 in 
corneal cells, changing transcriptional signals by 
demethylating CpG islands (Nishikiori et al., 2008); 
additionally, the epigenetic regulators increase 
transendothelial electrical resistance and suppress 
fluxes of corneal cells, thus enhancing the corneal 




Claudins are the gatekeepers of the paracellular 
pathway, and claudin isoform expression determines 
the permeability characteristics of the paracellular 
pathway. Claudin-9 is not expressed or barely 
detectable in the adult mouse but it is expressed in the 
neonatal mouse kidney. Claudin-9 mRNA is present in 
1-day-old proximal convoluted tubules (Abuazza et al., 
2006). Expression of claudin-9 results in an increased 
transepithelial resistance, decreased chloride 
permeability, and decreased P(Na)/P(Cl) and 
P(HCO3)/P(Cl) (Sas et al. 2008). Claudin-9 may play a 




Transmembrane proteins of the claudin family are 
critical determinants of TJ permeability but little is 
known about the signaling pathways that control their 
expression.  
In mammary epithelial cells SP600125 (an inhibitor of 
Jun N-terminal kinase) increased claudin-9 expression 
whereas PD169316 (a p38 MAPK inhibitor) did not 
modify claudin-9 expression (Carrozzino et al., 2009). 
Claudin-9 expression is associated with cellular stres . 
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